KOBAYASHI PHARMACEUTICAL's consensus forecast for ordinary profit for the fiscal year ending December 2026 fell 0.3% week on week to ¥13,688 million, above the company's forecast of ¥13,000 million. The rating consensus also declined from 2.7 to 2.6.
KOBAYASHI PHARMACEUTICAL's consensus forecast for ordinary profit for the fiscal year ending December 2026 fell 0.3% from the previous week's ¥13,738 million to ¥13,688 million.
The company's forecast is ¥13,000 million, and the current consensus forecast is above this level.
At the same time, the rating consensus declined from 2.7 to 2.6.